Lack of expression of E-cadherin is associated with dissemination of Langerhans' cell histiocytosis and poor outcome

Journal of Pathology

Volumn 181, Issue 3, 1997, Pages 301-304

  Geissmann, F ^a   Emile, J F ^a   Andry, P ^a   Thomas, C ^a   Fraitag, S ^a   De Prost, Y ^a   Brousse, N ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

E cadherin; Histiocytosis; Langerhans' cell; Prognosis

Indexed keywords

INTEGRIN; UVOMORULIN;

ARTICLE; CLINICAL ARTICLE; FROZEN SECTION; HISTIOCYTOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LANGERHANS CELL; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; SKIN BIOPSY;

BIOLOGICAL MARKERS; CADHERINS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HISTIOCYTOSIS, LANGERHANS-CELL; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INFANT, NEWBORN; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN DISEASES;

EID: 0031004523     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199703)181:3<301::AID-PATH779>3.0.CO;2-2     Document Type: Article

References (13)

1. Nezelof C, Basset F, Rousseau M. Histiocytosis X: histogenetic arguments for a Langerhans cell origin. Biomedicine 1973; 18: 365-371.
2. Willman CL, Busqué L, Griffith BB, et al. Langerhans cell histiocytosis (histiocytosis X): a clonal proliferative disease. N Engl J Med 1994; 331: 154-160.
3. Emile JF, Fraitag S, Leborgne M, De Prost Y, Brousse N. Langerhans' cell histiocytosis cells are activated Langerhans' cells. J Pathol 1994; 174: 71-76.
4. Nezelhof C, Frileux-Herbet, F, Cronier-Sachot J. Disseminated histiocytosis X: Analysis of prognostic factors based on a retrospective study of 50 cases. Cancer 1979; 44: 1824-1838.
5. Ladish S, Gadner H, Arico M. LCH-1. a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society. Med Pediatr Oncol 1994; 23: 107-110.
6. Takeichi M. Cadherin cell adhesion receptors as a morphogenic regulator. Science 1991; 251: 1451-1455.
7. Tang A, Masayuki A, Granger LG, Stanley JR, Udey MC. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature 1993; 361: 82.
8. Cepek KL, Shaw SK, Parker CM, et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature 1994; 372: 190-193.
9. Becker A, Atkinson M, Reich U, et at. E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994; 54: 3845-3852.
10. Vleminckx K, Vakaet L, Mareel MJ, Fiers W, Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumour cells reveals an invasion suppressor role. Cell 1991; 66: 107-119.
11. Writing Group of the Histiocyte Society (Chu T, D'Angio GJ, Favara B, Ladish S, Nesbit M, Pritchard J). Histiocytosis syndromes in children. Lancet 1987; 1: 208-209.
12. Mason D, Sammons R. The labeled antigen method of immunoenzymatic staining. J Histochem Cytochem 1979; 27: 832-840.
13. Lefrancois L, Barret T, Havran W, Puddington L. Developmental expression of the alphaIELbeta7 integrin on T-cell receptor gamma-delta and T-cell receptor alpha-beta T cells. Eur J lmmunol 1994; 24: 635.